Please note that the application instructions for Chalmers students have been updated.
The major change is that the interviews will take place during May 6th – May 8th
Jamal El-Mosleh (Alumni from GIBBS/BIO’06) is on top of Veckans Affärers list of 101 Super Talents (Årets Supertalang). Jamal is the CEO of Immunicum, which develops cancer vaccines.
- “It is an honor to be mentioned on this list, and to top it naturally feels very funny. Personally, I am grateful, but I hope above all that this publicity can help cancer patients”, says Jamal El-Mosleh, who is passionate about his mission to cure cancer.
At the age of 26, Jamal was recruited as the CEO of the new company Immunicum AB in Gothenburg. The company’s patented vaccine is based on over 30 years of research in the field of transplantation immunology and activates the body’s own immune system to attack tumour cells. The company has since its foundation five years ago moved from laboratory tests to currently conduct clinical phase I / II trials in renal cancer patients. To lead such a business requires hard work and knowledge, but also talent. The success of the company puts Jamal on top of Veckans Affärers list of Super Talents, which justifies the award of the following:
”Jamal El-Mosleh has single-handedly driven the company systematically from laboratory and animal studies to human clinical studies and preparation for vaccine production. He has taken the company through three rounds of private financing to an impending IPO, from a single patent to six patent families. He also has the communicative talent to understand complex research context and make them understandable to the general public. ”
Chalmers School of Entrepreneurship sends it´s warm and proud congratulations.
Immunicum AB (publ)
Immunicum developing vaccines for therapeutic treatment of cancer. The patented technology is based on over 30 years of research in the field of transplantation immunology and activates the body’s own immune system to attack harmful substances like tumour cells. Unlike most competing immunotherapies are vaccines possible to mass-produce.
Today our Incubation partner Encubator AB presented their new CEO.
On March 1st Linnéa Lindau signs on as the new CEO of Encubator. Current CEO Morgan Skarin becomes CEO of the portfolio company Tajitsu Industries.
Linnéa is 35 years old and most recently worked as CEO of one of Encubator’s portfolio companies – Acosense. Before that, she worked for ten years as a business coach at Chalmers Innovation, a job that involved identifying, funding and transforming technology-based ideas to verified business models established on the market. Linnéa therefore has experience from start-ups, board work and guiding growth companies. In addition, she has served as CEO of two technology-based companies and has been a board member of both the foundation Chalmers university of technology and Encubator. Linnea is a graduate from Chalmers, Automation & Mechatronics and an alumnus from Chalmers School of Entrepreneurship.
Welcome (back) Linnéa!
Last week four of our ICM students; Alexander Leppänen, Oscar Petersson, Fredrik Jern, and Nigel Wong won the TIMES Semi-final Case Competition held by ESTIEM in Kaiserslautern, Germany.
The Tournament In Management and Engineering Skills (TIMES) is the largest pan-European case study competition for Industrial Engineering and Management students. This prestigious, highly acclaimed event has successfully been organised since 1994 and attracts around 250 top teams each year. There are 7 semi-finals held in 7 different cities throughout Europe. The winner of each (including our ICM-students) goes through to the finals in Munich in April.
“Our success is largely due to our business case problem solving, strong presentation skills, and most of all, our solid team work! All of which is something developed over the duration of the ICM programme at Chalmers School of Entrepreneurship” says Nigel Wong.
Nice Work and Good Luck!!
ESTIEM is the organisation for European Students of Industrial Engineering and Management, who combine technological understanding with management skills. The goal of Estiem is to establish and foster relations between students across Europe and to support them in their personal and professional development. The network consists of 68 Local Groups in 26 countries, reaching out to 50 000 students.